In Heart Failure Patients, Severe Hyperkalemia Less Common with Sacubitril/Valsartan Than Enalapril (FREE)
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Among patients with heart failure who are taking a mineralocorticoid receptor antagonist (MRA), the risk for severe hyperkalemia is lower …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news